×
Sign in
Menu
Home
Resources
Back To Top
×
Contact the Presenter
×
Add To Cart
×
Test
ESMO Immuno-Oncology Congress 2022
Final Programme PDF
Advanced Search
07.12.2022
08.12.2022
09.12.2022
Collaborative session
Controversy session
Educational session
Industry satellite symposium
Mini Oral session
Poster Display session
Special session
Young Oncologists (YO) session
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
Foyer ABC
12:30(45m)
Poster Display
Room A
13:15(1h)
Bristol Myers Squibb - Exploring new advancements in chemokine signaling in tumor biology: Focus on IL-8, CXCR1, and CXCR2
14:30(1h)
Combination of radiotherapy and immunotherapy is a good idea
16:00(1h 30m)
GU malignancies
11:00(1h 30m)
H&N cancers
09:00(1h 30m)
Novel clinical and translational insights in melanoma
17:45(1h)
Sanofi - Utilizing immunohistochemistry testing, biomarkers, and targeted therapeutics to optimize outcomes in patients with NSCLC
Room B
11:00(1h 30m)
B cells as a therapeutic opportunity
09:00(1h 30m)
Imaging biomarkers in IO for cancer
14:30(1h 05m)
Mini Oral session 2
16:00(1h 30m)
Tumour and immunometabolism
Room C
09:00(1h 10m)
Mini Oral session 1
16:00(1h 30m)
Next generation technologies for the optimal implementation of immunotherapy
14:30(1h)
Session in collaboration with SITC: Moving beyond just T cells in the TME
11:00(1h 30m)
Tumour microenvironment
Foyer mezzanine
12:30(45m)
Poster Display
Room K
13:15(45m)
Vesalius talk: Overcoming the fear of leading: How to become a leader in your research group
×
Dialog
×
Sponsored Access
Access to the resources are offered to you by
ESMO Events